Charlie Strange to Cyclophosphamide
This is a "connection" page, showing publications Charlie Strange has written about Cyclophosphamide.
Connection Strength
0.469
-
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):91-8.
Score: 0.282
-
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719.
Score: 0.130
-
Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med. 2004 Sep; 25(3):549-59, vii.
Score: 0.057